Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Guerreiro

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
Cells|February 23, 2020
CD38 in Neurodegeneration and NeuroinflammationSerge Guerreiro, Anne-Laure Privat, Laurence Bressac, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson diseasePatrick P Michel, Damien Toulorge, Serge Guerreiro, et al.
Journal of Neurochemistry|May 12, 2010
KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasisDamien Toulorge, Serge Guerreiro, Etienne C Hirsch, et al.
Molecular Pharmacology|July 16, 2008
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channelsSerge Guerreiro, Damien Toulorge, Etienne Hirsch, et al.
Molecular Pharmacology|January 2, 2015
The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotineSerge Guerreiro, Clélia Florence, Erwann Rousseau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2011
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+Damien Toulorge, Serge Guerreiro, Audrey Hild, et al.
Journal of Neurochemistry|April 4, 2007
Role of activity-dependent mechanisms in the control of dopaminergic neuron survivalPatrick P Michel, Daniel Alvarez-Fischer, Serge Guerreiro, et al.
Journal of Neurochemistry|March 24, 2009
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarizationSerge Guerreiro, Aurélie Ponceau, Damien Toulorge, et al.
Glia|July 26, 2016
A simplified approach for efficient isolation of functional microglial cells: Application for modeling neuroinflammatory responses in vitroJulia E Sepulveda-Diaz, Mohand O Ouidja, Sergio B Socias, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
Cells|February 23, 2020
CD38 in Neurodegeneration and NeuroinflammationSerge Guerreiro, Anne-Laure Privat, Laurence Bressac, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson diseasePatrick P Michel, Damien Toulorge, Serge Guerreiro, et al.
Journal of Neurochemistry|May 12, 2010
KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasisDamien Toulorge, Serge Guerreiro, Etienne C Hirsch, et al.
Molecular Pharmacology|July 16, 2008
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channelsSerge Guerreiro, Damien Toulorge, Etienne Hirsch, et al.
Molecular Pharmacology|January 2, 2015
The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotineSerge Guerreiro, Clélia Florence, Erwann Rousseau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2011
Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+Damien Toulorge, Serge Guerreiro, Audrey Hild, et al.
Journal of Neurochemistry|April 4, 2007
Role of activity-dependent mechanisms in the control of dopaminergic neuron survivalPatrick P Michel, Daniel Alvarez-Fischer, Serge Guerreiro, et al.
Journal of Neurochemistry|March 24, 2009
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarizationSerge Guerreiro, Aurélie Ponceau, Damien Toulorge, et al.
Glia|July 26, 2016
A simplified approach for efficient isolation of functional microglial cells: Application for modeling neuroinflammatory responses in vitroJulia E Sepulveda-Diaz, Mohand O Ouidja, Sergio B Socias, et al.
Pageof 2